Chimeric Antigen Receptor T Cells in Multiple Myeloma

被引：1
|
作者：
Shah, Parth [1 ,2 ,4 ]
Sperling, Adam S. [2 ,3 ]
机构：
[1] Dartmouth Canc Ctr, Dept Hematol, 1 Med Ctr Dr, Lebanon, NH 03750 USA
[2] Dana Farber Canc Inst, Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA
[4] 1 Med Ctr Dr, Lebanon, NH 03750 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
Multiple myeloma; CAR-T; BCMA; GPRC5D; BiTEs; THERAPY; BCMA; MALIGNANCIES; MATURATION; ANTIBODY; COMBINATION; TRANSPLANT; EXPRESSION; PHASE-1; FUSION;
D O I：
10.1016/j.hoc.2023.05.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1089 / 1105
页数：17
相关论文
共 50 条
  • [21] Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challenges
    Binod Dhakal
    Parameswaran N. Hari
    Saad Z. Usmani
    Mehdi Hamadani
    Bone Marrow Transplantation, 2021, 56 : 9 - 19
  • [22] MECHANISMS OF RESISTANCE TO CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IN MULTIPLE MYELOMA
    Camviel, N.
    Wolf, B.
    Croce, G.
    Gfeller, D.
    Zoete, V.
    Arber, C.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A12 - A13
  • [23] Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challenges
    Dhakal, Binod
    Hari, Parameswaran N.
    Usmani, Saad Z.
    Hamadani, Mehdi
    BONE MARROW TRANSPLANTATION, 2021, 56 (01) : 9 - 19
  • [24] Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma
    Padda, Jaskamal
    Khalid, Khizer
    Zubair, Ujala
    Peethala, Mounika M.
    Kakani, Varsha
    Goriparthi, Lakshmi
    Almanie, Abdulelah H.
    Cooper, Ayden Charlene
    Jean-Charles, Gutteridge
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [25] The promise of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma
    Feinberg, Daniel
    Paul, Barry
    Kang, Yubin
    CELLULAR IMMUNOLOGY, 2019, 345
  • [26] Treatment of relapsed or refractory multiple myeloma with bb2121 chimeric antigen receptor T cells
    Stocker, Nicolas
    HEMATOLOGIE, 2021, 27 (02): : 46 - 47
  • [27] Fast and furious: Changing gears on the road to cure with chimeric antigen receptor T cells in multiple myeloma
    Gagelmann, Nico
    Merz, Maximilian
    SEMINARS IN HEMATOLOGY, 2024, 61 (05) : 306 - 313
  • [28] Chimeric antigen receptor-modified T cells against several target antigens in multiple myeloma
    Chang, Lung-Ji
    Liu, Yuchen
    Kuo, Hao-Hsiang
    Tsao, Shih-Ting
    Moreb, Jan S.
    CANCER RESEARCH, 2015, 75
  • [29] Chimeric Antigen Receptor T Cells for Multiple Myeloma The Journey So Far-And the Road Ahead
    Cowan, Andrew J.
    Tuazon, Sherilyn A.
    Portuguese, Andrew J.
    Green, Damian J.
    CANCER JOURNAL, 2021, 27 (02): : 112 - 118
  • [30] CD38 Chimeric Antigen Receptor Engineered T Cells As Therapeutic Tools for Multiple Myeloma
    Drent, Esther
    Groen, Richard
    Noort, Willy A.
    van Bueren, Jeroen Lammerts
    Parren, Paul W. H. I.
    Kuball, Jurgen H.
    Sebestyen, Zsolt
    van de Donk, Niels W. C. J.
    Martens, Anton C.
    Lokhorst, Henk M.
    Mutis, Tuna
    BLOOD, 2014, 124 (21)
12345